<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Cervical lymphadenitis in children: Diagnostic approach and initial management
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Cervical lymphadenitis in children: Diagnostic approach and initial management
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Cervical lymphadenitis in children: Diagnostic approach and initial management
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            C Mary Healy, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Morven S Edwards, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Jan E Drutz, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Glenn C Isaacson, MD, FAAP
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Diane Blake, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Mar 11, 2022.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         The evaluation and initial treatment of cervical lymphadenitis in children will be reviewed here. The pathogenesis, etiology, and clinical manifestations of cervical lymphadenitis and other causes of peripheral lymphadenopathy in children are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/5982.html" rel="external">
          "Cervical lymphadenitis in children: Etiology and clinical manifestations"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2871.html" rel="external">
          "Peripheral lymphadenopathy in children: Etiology"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2867.html" rel="external">
          "Peripheral lymphadenopathy in children: Evaluation and diagnostic approach"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          DEFINITIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Cervical lymphadenopathy – Enlarged lymph node(s) of the neck, including preauricular, parotid, jugulodigastric, submental, submandibular, posterior cervical, superficial cervical, deep cervical, occipital, and posterior auricular (mastoid)  (
         <a class="graphic graphic_figure graphicRef69528" href="/z/d/graphic/69528.html" rel="external">
          figure 1
         </a>
         ); lymphadenopathy encompasses both inflamed and noninflamed lymph nodes.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Cervical lymphadenitis – Enlarged, inflamed, and tender lymph node(s) of the neck; although strictly speaking, "lymphadenitis" refers to inflamed lymph nodes, the terms "lymphadenitis" and "lymphadenopathy" often are used interchangeably.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Acute lymphadenitis – Develops over a few days (but may persist for weeks to months).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Subacute/chronic lymphadenitis – Develops over weeks to months.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Generalized lymphadenopathy – Enlargement of two or more noncontiguous lymph node regions (eg, cervical and axillary) and is the result of systemic disease. (See
         <a class="medical medical_review" href="/z/d/html/2871.html" rel="external">
          "Peripheral lymphadenopathy in children: Etiology", section on 'Generalized lymphadenopathy'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H454195023">
         <span class="h1">
          CAUSES
         </span>
         <span class="headingEndMark">
          —
         </span>
         There are numerous infectious and noninfectious causes of enlarged cervical lymph nodes in children  (
         <a class="graphic graphic_table graphicRef56712" href="/z/d/graphic/56712.html" rel="external">
          table 1
         </a>
         and
         <a class="graphic graphic_table graphicRef77911" href="/z/d/graphic/77911.html" rel="external">
          table 2
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/5982.html" rel="external">
          "Cervical lymphadenitis in children: Etiology and clinical manifestations"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h1">
          DIAGNOSTIC APPROACH
         </span>
        </p>
        <p class="headingAnchor" id="H3703176490">
         <span class="h2">
          Overview
         </span>
         <span class="headingEndMark">
          —
         </span>
         The evaluation of children with cervical lymphadenitis includes a thorough history and physical examination  (
         <a class="graphic graphic_table graphicRef97722" href="/z/d/graphic/97722.html" rel="external">
          table 3
         </a>
         ) [
         <a href="#rid1">
          1
         </a>
         ]. The goal of the evaluation is to determine the underlying cause, which affects initial management.
        </p>
        <p>
         The initial laboratory evaluation and management depend upon the findings from the history and examination, and may range from observation and reassurance (for well-appearing children with acute bilateral cervical lymphadenitis that is only slightly enlarged and minimally tender) to comprehensive diagnostic testing and aggressive medical and surgical therapy (for ill-appearing children or those with suspected malignancy or mycobacterial disease). In difficult cases, consultation with a specialist in pediatric infectious diseases can help to direct the evaluation and management.
        </p>
        <p>
         Unless there are compelling associated symptoms suggestive of noninfectious causes  (
         <a class="graphic graphic_table graphicRef77911" href="/z/d/graphic/77911.html" rel="external">
          table 2
         </a>
         ), we generally focus the initial evaluation on infectious causes of cervical lymphadenitis because infectious causes are more common and more frequently associated with tenderness and inflammation than noninfectious causes.
        </p>
        <p>
         The infectious causes of cervical lymphadenitis in children vary depending upon whether the adenitis is acute or subacute/chronic and bilateral or unilateral, although there is some overlap  (
         <a class="graphic graphic_table graphicRef56712" href="/z/d/graphic/56712.html" rel="external">
          table 1
         </a>
         ). We use this categorization in conjunction with the findings from the history and examination to guide the initial laboratory evaluation and management. (See
         <a class="local">
          'Initial laboratory evaluation and management'
         </a>
         below.)
        </p>
        <p>
         Additional testing depends upon the results of the initial evaluation and the clinical course, including the response to antimicrobial therapy if it is initiated. (See
         <a class="local">
          'Additional evaluation for persistence or uncertain etiology'
         </a>
         below.)
        </p>
        <p>
         The pace of the diagnostic evaluation is dictated by how ill the patient appears. As an example, early excisional biopsy is indicated for children with features suggestive of malignancy or nontuberculous mycobacterial infection. (See
         <a class="local">
          'Suspected malignancy'
         </a>
         below and
         <a class="local">
          'Suspected NTM'
         </a>
         below and
         <a class="local">
          'Additional evaluation for persistence or uncertain etiology'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h2">
          History
         </span>
         <span class="headingEndMark">
          —
         </span>
         Important aspects of the history in a child with cervical lymphadenitis include [
         <a href="#rid1">
          1
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Duration and laterality of enlargement and change in size over time
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Associated symptoms, particularly fever; constitutional symptoms (weight loss, fatigue, malaise); conjunctivitis; pharyngitis; nasal, aural, or sinus obstruction without discharge; dental problems or mouth sores; cough; gastrointestinal symptoms; arthralgia; skin lesions or trauma
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Immunization status (diphtheria, measles, mumps, rubella)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Exposures:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Ill contacts (viral respiratory infections, cytomegalovirus [CMV], Epstein-Barr virus [EBV],
         <em>
          Streptococcus pyogenes
         </em>
         [group A
         <em>
          Streptococcus
         </em>
         , GAS], tuberculosis)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Ingestion of unpasteurized animal milk (brucellosis,
         <em>
          Mycobacterium bovis
         </em>
         ) or undercooked meats (toxoplasmosis)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Animal exposures (cat scratch disease, toxoplasmosis [cats], brucellosis [especially goats], tularemia [especially rabbits], bubonic plague [especially prairie dogs])
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Flea or tick bites (bubonic plague, tularemia)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Medications (eg,
         <a class="drug drug_pediatric" data-topicid="12702" href="/z/d/drug information/12702.html" rel="external">
          phenytoin
         </a>
         ,
         <a class="drug drug_pediatric" data-topicid="13113" href="/z/d/drug information/13113.html" rel="external">
          carbamazepine
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Geographic location and travel within the United States (
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.cdc.gov%2Ftularemia%2Fstatistics%2Findex.html&amp;token=WvyjRnzAIhBLkt0DpXZImC%2FE%2B9vOVPep%2BanwvYR0K3wUgUVcOSHxr4ChUvx26InmhdU46kkZWEdDS7R9Y1MXWQ%3D%3D&amp;TOPIC_ID=6061" target="_blank">
          tularemia
         </a>
         ,
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.cdc.gov%2Fplague%2Fmaps%2Findex.html&amp;token=R4Uiw8%2FbmPVaqNHRDqpXLJJxwS%2F5izkNKwzOrUpupszs4Qz5mZ%2FcUd%2BvJUBQ3sIY6WLR%2BgFfNxgqHKqdRbI%2B1w%3D%3D&amp;TOPIC_ID=6061" target="_blank">
          bubonic plague
         </a>
         ,
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.cdc.gov%2Ftb%2Fstatistics%2Fdefault.htm&amp;token=iECcO6YKFe1MNQTmx73isg1dRF9Ve6JVwYPdUpkBtRWi5x%2BlYPkcKI%2FvhCa9XoMmPc5uGRxCDPk%2FpYzGsTyAYA%3D%3D&amp;TOPIC_ID=6061" target="_blank">
          tuberculosis
         </a>
         ) and internationally (
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.cdc.gov%2Fplague%2Fmaps%2Findex.html&amp;token=R4Uiw8%2FbmPVaqNHRDqpXLJJxwS%2F5izkNKwzOrUpupszs4Qz5mZ%2FcUd%2BvJUBQ3sIY6WLR%2BgFfNxgqHKqdRbI%2B1w%3D%3D&amp;TOPIC_ID=6061" target="_blank">
          bubonic plague
         </a>
         , tuberculosis  (
         <a class="graphic graphic_figure graphicRef55097" href="/z/d/graphic/55097.html" rel="external">
          figure 2
         </a>
         ))
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h2">
          Physical examination
         </span>
         <span class="headingEndMark">
          —
         </span>
         A comprehensive physical examination should be performed to look for signs of systemic disease or infection [
         <a href="#rid1">
          1
         </a>
         ]. Special attention should be given to the lymphatic system, conjunctivae, oral cavity, and skin.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Lymphatic system – Examination of the lymphatic system includes the liver, spleen, and cervical and noncervical lymph nodes.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Hepatosplenomegaly with generalized adenitis may indicate systemic infection (eg EBV, CMV, human immunodeficiency virus [HIV], histoplasmosis, tuberculosis, syphilis) or noninfectious etiology (eg, malignancy, collagen vascular disease  (
         <a class="graphic graphic_table graphicRef77911" href="/z/d/graphic/77911.html" rel="external">
          table 2
         </a>
         )).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Assessment of the lymph nodes should include the number, location  (
         <a class="graphic graphic_figure graphicRef69528" href="/z/d/graphic/69528.html" rel="external">
          figure 1
         </a>
         ), size, shape, consistency, tenderness, mobility, and color of overlying skin.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         "Reactive" lymph nodes usually feel soft and are discrete, mobile, and minimally tender; they are often referred to as "shotty" (ie, small and round, like shotgun pellets).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Infected lymph nodes are usually isolated, asymmetric, tender, warm, and erythematous; they may be fluctuant; they are less mobile and discrete than reactive lymph nodes.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Malignant lymph nodes often are hard, fixed, or matted to the underlying structures; they usually are nontender.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Eyes – Conjunctival injection may indicate:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Parinaud oculoglandular syndrome  (
         <a class="graphic graphic_picture graphicRef97723" href="/z/d/graphic/97723.html" rel="external">
          picture 1
         </a>
         ) (associated with cat scratch disease or tularemia) (see
         <a class="medical medical_review" href="/z/d/html/5532.html" rel="external">
          "Microbiology, epidemiology, clinical manifestations, and diagnosis of cat scratch disease"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Adenovirus (eg, pharyngoconjunctival fever)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Kawasaki disease  (
         <a class="graphic graphic_picture graphicRef78898" href="/z/d/graphic/78898.html" rel="external">
          picture 2
         </a>
         ) (see
         <a class="medical medical_review" href="/z/d/html/6417.html" rel="external">
          "Kawasaki disease: Clinical features and diagnosis"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Multisystem inflammatory disease in children (MIS-C) (see
         <a class="medical medical_review" href="/z/d/html/128190.html" rel="external">
          "COVID-19: Multisystem inflammatory syndrome in children (MIS-C) clinical features, evaluation, and diagnosis"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Oral cavity – The oral cavity should be examined for periodontal disease, ulcers  (
         <a class="graphic graphic_picture graphicRef58566 graphicRef71314" href="/z/d/graphic/58566.html" rel="external">
          picture 3A-B
         </a>
         ), herpes simplex virus (HSV) gingivostomatitis  (
         <a class="graphic graphic_picture graphicRef58944" href="/z/d/graphic/58944.html" rel="external">
          picture 4
         </a>
         ), or pharyngitis.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Skin – A generalized rash may suggest a nonspecific viral illness (eg, roseola, adenovirus, EBV, measles, rubella, parvovirus B19), Kawasaki disease, MIS-C, juvenile idiopathic arthritis, systemic lupus erythematosus, Langerhans cell histiocytosis, hemophagocytic lymphohistiocytosis.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         A localized skin lesion may indicate a more specific etiology:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Cat scratch disease  (
         <a class="graphic graphic_picture graphicRef78770 graphicRef59249" href="/z/d/graphic/78770.html" rel="external">
          picture 5A-B
         </a>
         ) (see
         <a class="medical medical_review" href="/z/d/html/5532.html" rel="external">
          "Microbiology, epidemiology, clinical manifestations, and diagnosis of cat scratch disease"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Tularemia  (
         <a class="graphic graphic_picture graphicRef52036" href="/z/d/graphic/52036.html" rel="external">
          picture 6
         </a>
         ) (see
         <a class="medical medical_review" href="/z/d/html/3141.html" rel="external">
          "Tularemia: Clinical manifestations, diagnosis, treatment, and prevention"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <em>
          Staphylococcus aureus
         </em>
         or GAS (see
         <a class="medical medical_review" href="/z/d/html/110529.html" rel="external">
          "Cellulitis and skin abscess: Epidemiology, microbiology, clinical manifestations, and diagnosis"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         HSV  (
         <a class="graphic graphic_picture graphicRef58542 graphicRef52029" href="/z/d/graphic/58542.html" rel="external">
          picture 7A-B
         </a>
         ) (see
         <a class="medical medical_review" href="/z/d/html/6046.html" rel="external">
          "Herpetic gingivostomatitis in young children"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Less common infections in which a papular or pustular lesion is suggestive of an inoculation site include [
         <a href="#rid2">
          2
         </a>
         ]:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Nocardia (see
         <a class="medical medical_review" href="/z/d/html/5515.html" rel="external">
          "Nocardia infections: Epidemiology, clinical manifestations, and diagnosis"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Actinomycosis (see
         <a class="medical medical_review" href="/z/d/html/3411.html" rel="external">
          "Cervicofacial actinomycosis"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Sporotrichosis  (
         <a class="graphic graphic_picture graphicRef74340" href="/z/d/graphic/74340.html" rel="external">
          picture 8
         </a>
         ) (see
         <a class="medical medical_review" href="/z/d/html/2457.html" rel="external">
          "Clinical features and diagnosis of sporotrichosis"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <em>
          Yersinia pestis
         </em>
         (see
         <a class="medical medical_review" href="/z/d/html/3131.html" rel="external">
          "Clinical manifestations, diagnosis, and treatment of plague (
          <i>
           Yersinia pestis
          </i>
          infection)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Cutaneous diphtheria
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H177366276">
         <span class="h2">
          Indications for admission
         </span>
         <span class="headingEndMark">
          —
         </span>
         Potential indications for hospital admission in children with cervical lymphadenitis include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Need for parenteral antimicrobial therapy:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Acute unilateral cervical lymphadenitis with severe symptoms (eg, ill-appearing, fever, fluctuant node, concomitant cellulitis) (see
         <a class="local">
          'Severe symptoms'
         </a>
         below)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Acute unilateral cervical lymphadenitis with moderate symptoms (eg, fever, nonfluctuant node) that do not respond to or worsen with oral antimicrobial therapy (see
         <a class="local">
          'Moderate symptoms'
         </a>
         below)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Consideration of Kawasaki disease or MIS-C (see
         <a class="medical medical_review" href="/z/d/html/6417.html" rel="external">
          "Kawasaki disease: Clinical features and diagnosis", section on 'Clinical manifestations'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/128190.html" rel="external">
          "COVID-19: Multisystem inflammatory syndrome in children (MIS-C) clinical features, evaluation, and diagnosis", section on 'Clinical manifestations'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Need for incision and drainage (see
         <a class="local">
          'Moderate symptoms'
         </a>
         below and
         <a class="local">
          'Severe symptoms'
         </a>
         below)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1227480773">
         <span class="h1">
          INITIAL LABORATORY EVALUATION AND MANAGEMENT
         </span>
        </p>
        <p class="headingAnchor" id="H8">
         <span class="h2">
          Acute bilateral
         </span>
         <span class="headingEndMark">
          —
         </span>
         Viral upper respiratory infection (URI) is the most common cause of acute bilateral cervical lymphadenitis  (
         <a class="graphic graphic_table graphicRef97716" href="/z/d/graphic/97716.html" rel="external">
          table 4
         </a>
         ) [
         <a href="#rid1">
          1
         </a>
         ]. The initial evaluation and management depend upon the child's clinical status and the course of the lymphadenitis. Although viral URI is the most common cause, evaluation may be necessary to identify causes that require specific therapy (eg, group A
         <em>
          Streptococcus
         </em>
         [GAS]).
        </p>
        <p class="headingAnchor" id="H9">
         <span class="h3">
          Mild illness
         </span>
         <span class="headingEndMark">
          —
         </span>
         Children with acute bilateral cervical lymph nodes that are slightly enlarged, minimally tender, and mobile and who are only mildly ill (ie, well-appearing, absent or low-grade fever, nonprogressive symptoms), generally do not require laboratory testing.
        </p>
        <p>
         However, testing for GAS is indicated in children with acute bilateral cervical lymphadenitis and exudative pharyngitis. Testing for
         <em>
          Arcanobacterium haemolyticum
         </em>
         may be warranted in adolescents with exudative pharyngitis. Testing for Epstein-Barr virus (EBV) may be warranted if the rapid test for GAS is negative or if the child has generalized lymphadenopathy and/or hepatosplenomegaly. (See
         <a class="medical medical_review" href="/z/d/html/8283.html" rel="external">
          "Clinical manifestations and treatment of Epstein-Barr virus infection", section on 'Primary infection'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5971.html" rel="external">
          "Group A streptococcal tonsillopharyngitis in children and adolescents: Clinical features and diagnosis", section on 'Diagnosis'
         </a>
         .)
        </p>
        <p>
         Specific treatment usually is not necessary, unless the child has GAS or
         <em>
          A. haemolyticum
         </em>
         . The lymph nodes should be monitored with serial examinations every few weeks until they regress. Follow-up should occur earlier than scheduled if the child develops new or worsening symptoms. (See
         <a class="local">
          'Severe, progressive, or persistent adenitis'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H627069606">
         <span class="h3">
          Severe, progressive, or persistent adenitis
         </span>
         <span class="headingEndMark">
          —
         </span>
         For children with acute bilateral cervical lymphadenitis who are ill-appearing, febrile, or have progressive or persistent symptoms (ie, for longer than six to eight weeks without diminishing in size), we suggest the following evaluation:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Complete blood count (CBC) with differential
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Erythrocyte sedimentation rate (ESR) and/or C-reactive protein (CRP)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Hepatic profile (looking for evidence of systemic involvement, but not necessarily for a specific pathogen)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Blood culture
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="drug drug_general" data-topicid="10029" href="/z/d/drug information/10029.html" rel="external">
          Tuberculin skin test
         </a>
         (TST) and/or interferon-gamma release assay (IGRA)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         EBV, cytomegalovirus (CMV), HIV serology; EBV serology is preferred to a monospot test because the monospot may be falsely negative in children
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Other serologic testing (eg,
         <em>
          Toxoplasma gondii
         </em>
         , syphilis, or brucellosis) as indicated by the history and examination
        </p>
        <p>
        </p>
        <p>
         Although some of the infections identified with these tests more commonly cause subacute/chronic cervical lymphadenitis or generalized lymphadenopathy, it is important to consider them in children who are severely ill or have progressive/persistent cervical lymphadenitis, especially if the infection requires specific therapy (eg, tuberculosis, HIV, syphilis, brucellosis).
        </p>
        <p>
         The CBC, ESR (and/or CRP), and hepatic profile are nonspecific tests that may provide information about inflammation, bone marrow suppression or infiltration, and systemic involvement. Abnormal results may prompt additional evaluation (eg, bone marrow biopsy in children with peripheral cytopenias or blasts). The remainder of the tests may help to establish an etiology and the need for specific therapy.
        </p>
        <p>
         Additional testing may be necessary if the child remains ill and the etiology remains uncertain. (See
         <a class="local">
          'Additional evaluation for persistence or uncertain etiology'
         </a>
         below.)
        </p>
        <p>
         The management of children with severe, progressive, or persistent cervical lymphadenitis depends upon the etiology. As examples:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/8283.html" rel="external">
          "Clinical manifestations and treatment of Epstein-Barr virus infection", section on 'Treatment'
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5965.html" rel="external">
          "Overview of cytomegalovirus infections in children", section on 'Treatment'
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/121314.html" rel="external">
          "Brucellosis: Treatment and prevention", section on 'Treatment'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H11">
         <span class="h2">
          Acute unilateral
         </span>
         <span class="headingEndMark">
          —
         </span>
         Acute unilateral cervical lymphadenitis in children usually is caused by
         <em>
          S. aureus,
         </em>
         GAS, or oral anaerobes (in children with poor oral hygiene or periodontal disease)  (
         <a class="graphic graphic_table graphicRef97718" href="/z/d/graphic/97718.html" rel="external">
          table 5
         </a>
         ) [
         <a href="#rid1">
          1,3
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5982.html" rel="external">
          "Cervical lymphadenitis in children: Etiology and clinical manifestations", section on 'Acute unilateral'
         </a>
         .)
        </p>
        <p>
         The initial evaluation and management depend upon the severity of symptoms.
        </p>
        <p class="headingAnchor" id="H12">
         <span class="h3">
          Minimal symptoms
         </span>
         <span class="headingEndMark">
          —
         </span>
         Children with acute unilateral cervical lymphadenitis who are well-appearing and whose lymph node is only slightly enlarged and minimally tender usually do not require laboratory testing.
        </p>
        <p>
         The lymph node should be monitored with serial examinations every few weeks until regression. Follow-up should occur earlier than scheduled if the child develops new or worsening symptoms. (See
         <a class="local">
          'Moderate symptoms'
         </a>
         below and
         <a class="local">
          'Severe symptoms'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H13">
         <span class="h3">
          Moderate symptoms
         </span>
         <span class="headingEndMark">
          —
         </span>
         In children with acute unilateral cervical lymphadenitis and moderate symptoms (eg, fever, warm and/or tender adenitis), we recommend a course of oral antimicrobial therapy after obtaining microbiologic specimens as indicated to guide therapy.
        </p>
        <p>
         The evaluation of children with acute unilateral cervical lymphadenitis and moderate symptoms may include [
         <a href="#rid4">
          4
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Blood cultures if the child is febrile and ill-appearing.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Cultures of draining skin lesions (if present); however, isolation of GAS from the skin does not necessarily confirm GAS as the cause of lymph node inflammation because the skin may be colonized with GAS [
         <a href="#rid5">
          5
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Throat culture (in children with exudative tonsillopharyngitis); however, isolation of GAS from the throat does not necessarily confirm GAS as the cause of lymph node inflammation because the throat may be colonized with GAS [
         <a href="#rid5">
          5
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Needle aspiration of the inflamed node (in children without exudative pharyngitis) or if the node is suppurative; samples should be sent for Gram stain, bacterial culture (aerobic and anaerobic), and susceptibilities. Although mycobacteria more typically present as subacute/chronic infections, acid-fast bacilli stain and mycobacterial culture should be obtained if the specimen is adequate (the acute infection that brought the child to medical attention may be superimposed on a subacute/chronic process).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         An infectious etiology is identified in 60 to 80 percent of patients who undergo needle aspiration or incision and drainage for bacterial and mycobacterial culture [
         <a href="#rid3">
          3,5,6
         </a>
         ]. Negative cultures do not absolutely exclude anaerobic infection, particularly in older children with poor oral hygiene or periodontal disease because anaerobes are fastidious organisms that require proper bacteriologic techniques for isolation [
         <a href="#rid7">
          7
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         We suggest that oral empiric antimicrobial therapy for children with acute unilateral cervical lymphadenitis and moderate symptoms include coverage for
         <em>
          S. aureus
         </em>
         and GAS. Coverage for anaerobes should be included in children with periodontal disease or poor oral hygiene. The choice of empiric regimen is influenced by the likelihood of methicillin- or clindamycin-resistant
         <em>
          S. aureus
         </em>
         (
         <a class="graphic graphic_table graphicRef97715" href="/z/d/graphic/97715.html" rel="external">
          table 6
         </a>
         )
         <em>
         </em>
         [
         <a href="#rid8">
          8
         </a>
         ]. Antimicrobial treatment should be adjusted according to the culture and susceptibility results once they are available. The total length of therapy is usually 10 to 14 days [
         <a href="#rid2">
          2
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6065.html" rel="external">
          "Methicillin-resistant
          <i>
           Staphylococcus aureus
          </i>
          infections in children: Epidemiology and clinical spectrum", section on 'CA-MRSA strains'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6027.html" rel="external">
          "Skin and soft tissue infections in children &gt;28 days: Evaluation and management", section on 'Management approach'
         </a>
         .)
        </p>
        <p>
         Referral to a dentist may be warranted for children with underlying periodontal disease and/or poor oral hygiene [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p>
         Follow-up within 48 to 72 hours is necessary to ensure clinical response (eg, decreased maximum daily temperature and decreased inflammation and tenderness of the node) [
         <a href="#rid2">
          2
         </a>
         ]. However, it may take four to six weeks for the lymph node to regress in size.
        </p>
        <p>
         Failure to improve within 48 to 72 hours may indicate infection with a resistant organism (eg, methicillin-resistant or clindamycin-resistant
         <em>
          S. aureus
         </em>
         ). If not performed previously, needle aspiration or incision and drainage for Gram stain, culture, and susceptibilities may be indicated [
         <a href="#rid3">
          3,9
         </a>
         ]. It may be necessary to broaden antimicrobial therapy to include coverage for resistant organisms, or less common organisms if clinically indicated [
         <a href="#rid10">
          10
         </a>
         ]. (See
         <a class="local">
          'Additional evaluation for persistence or uncertain etiology'
         </a>
         below.)
        </p>
        <p>
         Occasionally, symptoms progress despite appropriate antimicrobial therapy and the patient requires hospitalization, parenteral therapy, and an incision and drainage procedure. Antimicrobial therapy is usually continued for seven days after the time of drainage.
        </p>
        <p class="headingAnchor" id="H14">
         <span class="h3">
          Severe symptoms
         </span>
         <span class="headingEndMark">
          —
         </span>
         For most children who have acute unilateral cervical lymphadenitis and severe symptoms (eg, ill-appearing, fever, fluctuant nodes, or concomitant cellulitis), we recommend antimicrobial therapy after drainage of the inflamed node. It is also important to consider Kawasaki disease, given the importance of early treatment to prevent complications. (See
         <a class="local">
          'Suspected Kawasaki disease or MIS-C'
         </a>
         below.)
        </p>
        <p>
         The evaluation of children with acute unilateral cervical lymphadenitis and severe symptoms generally includes:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Blood cultures.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Drainage of fluctuant lymph node – Incision and drainage is preferred to needle aspiration to reduce the likelihood of reaccumulation of pus; children who undergo incision and drainage often require hospitalization and parenteral antimicrobial therapy for several days.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Abscess fluid and lymph node tissue (if obtained) should be sent for Gram stain, bacterial culture (aerobic and anaerobic), and susceptibilities; mycobacterial and fungal stains and cultures (mycobacteria and fungi more typically cause subacute/chronic lymphadenitis, but the acute infection that brought the child to medical attention may be superimposed on a subacute/chronic process); and histopathologic examination.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Ultrasonography of the lymph node is the diagnostic test of choice in evaluating a single neck mass suggestive of acute suppurative cervical lymphadenitis in a febrile child [
         <a href="#rid3">
          3
         </a>
         ]. Computed tomography (CT) with contrast may be required in some children before performing incision and drainage to detect unappreciated deep loculations. The need for CT should be balanced against the radiation exposure.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         ESR and/or CRP may be helpful in monitoring the course of infection and making decisions about switching from parenteral to oral antimicrobial therapy.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         If Kawasaki disease is a consideration, echocardiogram and electrocardiogram should be obtained [
         <a href="#rid11">
          11
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6417.html" rel="external">
          "Kawasaki disease: Clinical features and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         We suggest that empiric antimicrobial therapy for children with acute unilateral cervical lymphadenitis and severe symptoms be administered parenterally and include coverage for
         <em>
          S. aureus
         </em>
         and GAS. Coverage for anaerobes should be included in children with periodontal disease or poor oral hygiene. The choice of empiric regimen is influenced by the results of the Gram stain and the likelihood of methicillin- or clindamycin-resistant
         <em>
          S. aureus
         </em>
         (
         <a class="graphic graphic_table graphicRef97715" href="/z/d/graphic/97715.html" rel="external">
          table 6
         </a>
         ). Antimicrobial treatment should be adjusted according to the culture and susceptibility results once they are available.
        </p>
        <p>
         Children who are receiving appropriate antimicrobial therapy should have a clinical response within 48 to 72 hours (eg, decreased fever, decreased ESR/CRP [if previously measured]) [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p>
         After a few days of intravenous therapy, a switch usually can be made to oral therapy, guided by the results of culture, to complete a total of 10 to 14 days of therapy. Transition to oral therapy depends upon:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The clinical course (resolution of fever, decreased pain, decreased swelling and redness)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Improvement in ESR and CRP if previously measured
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Availability of an equivalent oral therapy
        </p>
        <p>
        </p>
        <p>
         If the child fails to respond to empiric therapy, uncommon and rare infectious causes  (
         <a class="graphic graphic_table graphicRef97718" href="/z/d/graphic/97718.html" rel="external">
          table 5
         </a>
         ) and noninfectious causes  (
         <a class="graphic graphic_table graphicRef77911" href="/z/d/graphic/77911.html" rel="external">
          table 2
         </a>
         ) of acute unilateral cervical lymphadenitis must be considered. If cultures remain negative, empiric antimicrobial therapy may need to be broadened to include coverage for resistant organisms (eg, methicillin-resistant
         <em>
          S. aureus
         </em>
         ). The history should be reviewed, with special attention to the following conditions:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Tularemia (see
         <a class="medical medical_review" href="/z/d/html/3130.html" rel="external">
          "Tularemia: Microbiology, epidemiology, and pathogenesis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3141.html" rel="external">
          "Tularemia: Clinical manifestations, diagnosis, treatment, and prevention"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         If tularemia is a consideration and initial serologic testing is negative, repeat serologic testing may be warranted because seroconversion occurs 10 to 20 days after infection [
         <a href="#rid12">
          12,13
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Alpha
         <em>
          Streptococcus
         </em>
         , associated with oral lesions
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <em>
          Pasteurella multocida
         </em>
         (see
         <a class="medical medical_review" href="/z/d/html/3129.html" rel="external">
          "Pasteurella infections"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <em>
          Y. pestis
         </em>
         (see
         <a class="medical medical_review" href="/z/d/html/3143.html" rel="external">
          "Epidemiology, microbiology and pathogenesis of plague (
          <i>
           Yersinia pestis
          </i>
          infection)"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3131.html" rel="external">
          "Clinical manifestations, diagnosis, and treatment of plague (
          <i>
           Yersinia pestis
          </i>
          infection)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <em>
          Yersinia enterocolitica
         </em>
         (see
         <a class="medical medical_review" href="/z/d/html/3139.html" rel="external">
          "Yersiniosis: Infection due to Yersinia enterocolitica and Yersinia pseudotuberculosis"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Gram-negative bacilli, associated with history of ear, nose, and throat infections; the isolation of gram-negative bacilli (eg,
         <em>
          Serratia
         </em>
         species) should prompt consideration of underlying immunodeficiency
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Anthrax (see
         <a class="medical medical_review" href="/z/d/html/5506.html" rel="external">
          "Microbiology, pathogenesis, and epidemiology of anthrax"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5533.html" rel="external">
          "Clinical manifestations and diagnosis of anthrax"
         </a>
         )
        </p>
        <p>
        </p>
        <p>
         Surgical excision, drainage, or biopsy may be necessary to obtain microbiologic specimens to guide changes to antimicrobial therapy. (See
         <a class="local">
          'Additional evaluation for persistence or uncertain etiology'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H1971777546">
         <span class="h2">
          Suspected Kawasaki disease or MIS-C
         </span>
         <span class="headingEndMark">
          —
         </span>
         Kawasaki disease or multisystem inflammatory disease in children (MIS-C) should be suspected in children with acute cervical lymphadenitis and persistent fever, ill-appearance, shock, myocardial dysfunction, or associated gastrointestinal symptoms  (
         <a class="graphic graphic_table graphicRef67711 graphicRef128294" href="/z/d/graphic/67711.html" rel="external">
          table 7A-B
         </a>
         ). Given the importance of early treatment, Kawasaki disease and MIS-C must be considered early in the evaluation of children with acute cervical lymphadenitis and severe symptoms. Enlarged lymph nodes associated with Kawasaki disease or MIS-C may not be particularly inflamed or fluctuant. Cardiac testing (eg, echocardiography) usually is included in the initial evaluation. (See
         <a class="medical medical_review" href="/z/d/html/6417.html" rel="external">
          "Kawasaki disease: Clinical features and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/128190.html" rel="external">
          "COVID-19: Multisystem inflammatory syndrome in children (MIS-C) clinical features, evaluation, and diagnosis"
         </a>
         .)
        </p>
        <p>
         Clinicians with experience caring for patients with Kawasaki disease or MIS-C should be consulted early in the course of the evaluation. These clinicians may include pediatric rheumatologists, infectious disease specialists, cardiologists, and/or hospitalists, depending upon the institution. (See
         <a class="medical medical_review" href="/z/d/html/6423.html" rel="external">
          "Kawasaki disease: Initial treatment and prognosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/129614.html" rel="external">
          "COVID-19: Multisystem inflammatory syndrome in children (MIS-C) management and outcome"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H15">
         <span class="h2">
          Subacute/chronic
         </span>
         <span class="headingEndMark">
          —
         </span>
         Unilateral subacute/chronic cervical lymphadenitis is usually caused by cat scratch disease or nontuberculous mycobacterial (NTM) infection  (
         <a class="graphic graphic_table graphicRef97720" href="/z/d/graphic/97720.html" rel="external">
          table 8
         </a>
         ) [
         <a href="#rid1">
          1,14
         </a>
         ]. However, the possibility of leukemia or lymphoma and other malignancies must be considered, particularly in adolescents  (
         <a class="graphic graphic_table graphicRef77911" href="/z/d/graphic/77911.html" rel="external">
          table 2
         </a>
         ). Bilateral subacute/chronic cervical lymphadenitis is usually caused by EBV or CMV  (
         <a class="graphic graphic_table graphicRef97719" href="/z/d/graphic/97719.html" rel="external">
          table 9
         </a>
         ).
        </p>
        <p>
         Information from the history, physical examination, and initial evaluation (eg, TST, serology) help to distinguish among these possibilities  (
         <a class="graphic graphic_table graphicRef77911" href="/z/d/graphic/77911.html" rel="external">
          table 2
         </a>
         and
         <a class="graphic graphic_table graphicRef97720" href="/z/d/graphic/97720.html" rel="external">
          table 8
         </a>
         and
         <a class="graphic graphic_table graphicRef97719" href="/z/d/graphic/97719.html" rel="external">
          table 9
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/5982.html" rel="external">
          "Cervical lymphadenitis in children: Etiology and clinical manifestations", section on 'Subacute/chronic unilateral'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5982.html" rel="external">
          "Cervical lymphadenitis in children: Etiology and clinical manifestations", section on 'Neoplasm'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1216641264">
         <span class="h3">
          Evaluation
         </span>
         <span class="headingEndMark">
          —
         </span>
         Our initial evaluation of children with subacute/chronic cervical lymphadenitis generally includes:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         CBC with differential and smear, ESR, and/or CRP (all of which may provide information about inflammation, bone marrow suppression or infiltration, and systemic involvement)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Hepatic panel
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Uric acid and lactate dehydrogenase (as a preliminary evaluation to exclude malignancy)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         TST with intermediate (5 tuberculin unit) purified protein derivative [
         <a href="#rid15">
          15
         </a>
         ] and IGRA
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Children who respond with 5 to 15 mm of induration at 48 hours may have NTM infection or tuberculosis (depending upon their risk for tuberculosis), whereas those with ≥15 mm induration usually have tuberculosis; however, reactions of 10 to 20 mm may occur with NTM [
         <a href="#rid15">
          15-17
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/86045.html" rel="external">
          "Nontuberculous mycobacterial lymphadenitis in children", section on 'M. tuberculosis'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/8001.html" rel="external">
          "Tuberculous lymphadenitis", section on 'Cervical lymphadenopathy'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         IGRA tests have high specificity, negative predictive value, and positive predictive value for tuberculosis lymphadenitis and are useful in differentiating tuberculosis from NTM in children with positive TST [
         <a href="#rid18">
          18
         </a>
         ]. IGRA tests usually are positive with tuberculosis but negative with NTM, with rare exception (eg,
         <em>
          Mycobacterium kansasii
         </em>
         ,
         <em>
          Mycobacterium marinum
         </em>
         ,
         <em>
          Mycobacterium szulgai, Mycobacterium flavescens
         </em>
         ) [
         <a href="#rid19">
          19
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/8020.html" rel="external">
          "Tuberculosis infection (latent tuberculosis) in children", section on 'Interferon-gamma release assays'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/8007.html" rel="external">
          "Tuberculosis disease in children: Epidemiology, clinical manifestations, and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Initial testing for children with subacute/chronic cervical lymphadenitis also may include:
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Serologic testing for HIV, EBV, and CMV (if the lymphadenitis is bilateral)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Serologic testing for
         <em>
          Bartonella henselae
         </em>
         if there is a clinical suspicion of cat scratch disease (see
         <a class="medical medical_review" href="/z/d/html/5532.html" rel="external">
          "Microbiology, epidemiology, clinical manifestations, and diagnosis of cat scratch disease", section on 'Approach to diagnosis'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Serology for tularemia, toxoplasmosis, or plague (
         <em>
          Y. pestis
         </em>
         ) if indicated based on history or examination. Although tularemia and
         <em>
          Y. pestis
         </em>
         typically cause acute cervical lymphadenitis, they should be considered in children with subacute/chronic lymphadenitis because they may require treatment (see
         <a class="medical medical_review" href="/z/d/html/3141.html" rel="external">
          "Tularemia: Clinical manifestations, diagnosis, treatment, and prevention"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/120887.html" rel="external">
          "Toxoplasmosis: Acute systemic disease"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3131.html" rel="external">
          "Clinical manifestations, diagnosis, and treatment of plague (
          <i>
           Yersinia pestis
          </i>
          infection)"
         </a>
         )
        </p>
        <p>
        </p>
        <p>
         If no etiology is identified with the above tests, excisional biopsy for histopathology, bacterial, mycobacterial, and fungal stains and cultures is usually indicated. (See
         <a class="local">
          'Additional evaluation for persistence or uncertain etiology'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H1216641277">
         <span class="h3">
          Management
         </span>
         <span class="headingEndMark">
          —
         </span>
         The initial management of children with subacute/chronic cervical lymphadenitis depends upon the suspected etiology.
        </p>
        <p class="headingAnchor" id="H1216641318">
         <span class="h4">
          Suspected malignancy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Excisional biopsy should occur as early in the course as possible if malignancy is suspected. (See
         <a class="local">
          'Additional evaluation for persistence or uncertain etiology'
         </a>
         below.)
        </p>
        <p>
         Malignancy should be suspected in children with unilateral, nontender, hard, persistent or progressive cervical lymphadenopathy and/or associated constitutional symptoms (eg, weight loss, fever, fatigue). Lack of evidence of viral infection (eg, HIV, EBV, CMV) increases suspicion for malignancy. (See
         <a class="medical medical_review" href="/z/d/html/5982.html" rel="external">
          "Cervical lymphadenitis in children: Etiology and clinical manifestations", section on 'Neoplasm'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6243.html" rel="external">
          "Overview of common presenting signs and symptoms of childhood cancer", section on 'Lymphadenopathy'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1216641371">
         <span class="h4">
          Suspected NTM
         </span>
         <span class="headingEndMark">
          —
         </span>
         The clinical appearance of NTM adenitis, especially when the overlying skin becomes violaceous and thin, is so characteristic that the diagnosis can frequently be made based upon the history and physical examination  (
         <a class="graphic graphic_picture graphicRef69475" href="/z/d/graphic/69475.html" rel="external">
          picture 9
         </a>
         ) [
         <a href="#rid20">
          20
         </a>
         ]. Excisional biopsy of the involved lymph node can provide a definitive diagnosis of NTM adenitis and is the preferred treatment, when it can be performed safely [
         <a href="#rid21">
          21
         </a>
         ]. Incision and complete curettage is an alternative when excisional biopsy cannot be performed. Incision and drainage are contraindicated, due to the risk of developing a chronically draining fistula.
        </p>
        <p>
         The clinical features, diagnosis, and management of NTM lymphadenitis in children are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/86045.html" rel="external">
          "Nontuberculous mycobacterial lymphadenitis in children"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H454196084">
         <span class="h4">
          Suspected cat scratch disease
         </span>
         <span class="headingEndMark">
          —
         </span>
         When cat scratch disease is suspected but not confirmed, empiric therapy should provide coverage for
         <em>
          S. aureus
         </em>
         and GAS  (
         <a class="graphic graphic_table graphicRef97715" href="/z/d/graphic/97715.html" rel="external">
          table 6
         </a>
         ), as well as for cat scratch disease.
        </p>
        <p>
         Oral agents that may be used for cat scratch disease include
         <a class="drug drug_pediatric" data-topicid="12937" href="/z/d/drug information/12937.html" rel="external">
          azithromycin
         </a>
         ,
         <a class="drug drug_pediatric" data-topicid="12767" href="/z/d/drug information/12767.html" rel="external">
          rifampin
         </a>
         , and
         <a class="drug drug_pediatric" data-topicid="12816" href="/z/d/drug information/12816.html" rel="external">
          trimethoprim-sulfamethoxazole
         </a>
         . Rifampin has an advantage of providing additive therapy to other antimicrobials against
         <em>
          S. aureus
         </em>
         and GAS. The treatment of cat scratch disease is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/5530.html" rel="external">
          "Treatment of cat scratch disease", section on 'Lymphadenitis'
         </a>
         .)
        </p>
        <p>
         Surgical excision is rarely necessary for cat scratch lymphadenitis. However, painful, suppurative nodes can be treated with needle aspiration(s) for symptomatic relief.
        </p>
        <p class="headingAnchor" id="H25">
         <span class="h1">
          ADDITIONAL EVALUATION FOR PERSISTENCE OR UNCERTAIN ETIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         If after the initial evaluation the etiology of the adenitis remains uncertain, or the adenitis has persisted for six to eight weeks with no response to antimicrobial therapy, additional testing may be indicated to assess uncommon or rare infectious causes  (
         <a class="graphic graphic_table graphicRef56712" href="/z/d/graphic/56712.html" rel="external">
          table 1
         </a>
         ) and noninfectious causes  (
         <a class="graphic graphic_table graphicRef77911" href="/z/d/graphic/77911.html" rel="external">
          table 2
         </a>
         ) of cervical lymphadenitis [
         <a href="#rid2">
          2
         </a>
         ].
        </p>
        <p>
         Depending upon which studies were performed as part of the initial evaluation and risk factors identified in the initial evaluation or re-evaluation, additional testing may include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Repeat complete blood count (CBC) with differential (which may provide information about inflammation, bone marrow suppression or infiltration, and systemic involvement)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Rapid plasma reagin or venereal disease research laboratory test for syphilis
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Serology for Epstein-Barr virus, cytomegalovirus, human herpesvirus-6, HIV, histoplasmosis, coccidioidomycosis, toxoplasmosis, tularemia,
         <em>
          B. henselae
         </em>
         , and brucella
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Chest radiograph (looking for mediastinal lymph nodes or mass)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Excisional biopsy – Indications for excisional biopsy may include:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Suspicion of malignancy (eg, CBC with blasts or abnormal counts; mediastinal mass or mediastinal lymphadenopathy on chest radiograph, constitutional symptoms, supraclavicular or lower cervical lymphadenitis, matted lymphadenopathy)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Suspicion of tuberculous or nontuberculous mycobacterial lymphadenitis
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Persistent (more than six to eight weeks without decreasing in size) or enlarging adenopathy with uncertain diagnosis
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Excisional biopsy of the largest and firmest palpable node should occur as early in the course as possible if malignancy or mycobacterial infection is suspected [
         <a href="#rid22">
          22
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/86045.html" rel="external">
          "Nontuberculous mycobacterial lymphadenitis in children", section on 'Diagnosis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The biopsy should be performed at a medical center specializing in the care of children, and the pathologist should know in advance there will be a lymph node biopsy. This will ensure the proper smears, stains, and cultures are performed. Biopsy specimens should be submitted for bacterial, mycobacterial, and fungal stains and cultures and histopathologic examination. Parts of the sample should not be fixed at the time of excision to allow for sensitive marker studies, such as immunophenotyping, cytogenetics, and molecular studies.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H26">
         <span class="h1">
          PROGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Cervical lymphadenitis spontaneously regresses in most children over the course of several weeks. Reactivation of inflammation may occur in children who have conditions that predispose to infection (eg, dermatitis, infestation, foreign body) or if there is an occult source of infection that was not adequately treated (eg, dental abscess).
        </p>
        <p class="headingAnchor" id="H27">
         <span class="h1">
          COMPLICATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Delayed diagnosis and initiation of appropriate therapy may result in a prolonged clinical course or complications [
         <a href="#rid2">
          2
         </a>
         ]. Persistent and recurrent lymphadenitis is the most frequent complication [
         <a href="#rid23">
          23
         </a>
         ]. Other complications vary depending upon the underlying etiology and include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Nontuberculous
         <em>
          Mycobacteria
         </em>
         – Development of a draining fistula, facial nerve palsy, wound infection, and/or scarring [
         <a href="#rid21">
          21,24
         </a>
         ] (see
         <a class="medical medical_review" href="/z/d/html/86045.html" rel="external">
          "Nontuberculous mycobacterial lymphadenitis in children", section on 'Clinical features'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/14425.html" rel="external">
          "Disseminated nontuberculous mycobacterial (NTM) infections and NTM bacteremia in children"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <em>
          S. aureus
         </em>
         – Abscess formation, cellulitis, bacteremia [
         <a href="#rid5">
          5
         </a>
         ]
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Group A
         <em>
          Streptococcus
         </em>
         – Abscess formation, cellulitis, bacteremia, acute glomerulonephritis [
         <a href="#rid6">
          6
         </a>
         ]
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H165517164">
         <span class="h1">
          INFORMATION FOR PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5
         <sup>
          th
         </sup>
         to 6
         <sup>
          th
         </sup>
         grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10
         <sup>
          th
         </sup>
         to 12
         <sup>
          th
         </sup>
         grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
        </p>
        <p>
         Here are the patient education articles that are relevant to this topic. We encourage you to print or email these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword[s] of interest.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Basics topic (see
         <a class="medical medical_basics" href="/z/d/html/17190.html" rel="external">
          "Patient education: Swollen neck nodes in children (The Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H28">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Causes
         </strong>
         – There are numerous infectious  (
         <a class="graphic graphic_table graphicRef56712" href="/z/d/graphic/56712.html" rel="external">
          table 1
         </a>
         ) and noninfectious causes  (
         <a class="graphic graphic_table graphicRef77911" href="/z/d/graphic/77911.html" rel="external">
          table 2
         </a>
         ) of cervical lymphadenitis. (See
         <a class="local">
          'Causes'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          History and examination
         </strong>
         – Important aspects of the history and examination include onset, laterality, duration, and qualities of the lymphadenitis; associated symptoms (eg, fever, weight loss) and examination findings (eg, conjunctivitis, rash, hepatosplenomegaly); immunizations status; and exposures  (
         <a class="graphic graphic_table graphicRef97722" href="/z/d/graphic/97722.html" rel="external">
          table 3
         </a>
         ). (See
         <a class="local">
          'History'
         </a>
         above and
         <a class="local">
          'Physical examination'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Initial laboratory evaluation and management
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Acute bilateral
         </strong>
         – Acute bilateral cervical lymphadenitis is usually caused by a self-limited viral upper respiratory infection  (
         <a class="graphic graphic_table graphicRef97716" href="/z/d/graphic/97716.html" rel="external">
          table 4
         </a>
         ) and requires only monitoring unless it is accompanied by severe symptoms, progresses, or persists. Acute bilateral cervical lymphadenitis usually does not require specific treatment. (See
         <a class="local">
          'Acute bilateral'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Acute unilateral
         </strong>
         – Acute unilateral lymphadenitis is usually caused by
         <em>
          Staphylococcus aureus
         </em>
         or group A
         <em>
          Streptococcus
         </em>
         (GAS)  (
         <a class="graphic graphic_table graphicRef97718" href="/z/d/graphic/97718.html" rel="external">
          table 5
         </a>
         ). The evaluation and management depend upon the child's clinical status and the course of lymphadenitis. (See
         <a class="local">
          'Acute unilateral'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Children who are well-appearing and have slightly enlarged nodes with minimal tenderness can be followed clinically with serial examination every few weeks until regression. (See
         <a class="local">
          'Minimal symptoms'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         For children who have moderate symptoms (warm and/or tender lymphadenitis), the evaluation is tailored to the clinical findings and may include blood cultures, cultures of draining skin lesions, throat culture, and needle aspiration or incision and drainage for Gram stain and cultures (aerobic and anaerobic), and mycobacterial culture and stain for acid-fast bacilli (if the specimen is adequate). (See
         <a class="local">
          'Moderate symptoms'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         For children who have severe symptoms (ill-appearing, fever, fluctuant nodes, concomitant cellulitis), the evaluation usually includes blood cultures, drainage of the inflamed node (Gram stain, bacterial, cultures [aerobic and anaerobic] and susceptibilities, mycobacterial and fungal stains and cultures, and histopathologic examination), erythrocyte sedimentation rate (ESR), and/or C-reactive protein (CRP). Echocardiogram and electrocardiogram should be obtained if Kawasaki disease is a consideration. (See
         <a class="local">
          'Severe symptoms'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         We recommend that children with moderate or severe symptoms be treated with antimicrobial therapy (
         <a class="grade" href="https:///uptodate/show/grade_2" rel="external">
          Grade 1B
         </a>
         ). Initial empiric therapy should provide coverage f
         <em>
          or S. aureus and
         </em>
         GAS; coverage for anaerobes should be included in patients with periodontal disease or poor oral hygiene  (
         <a class="graphic graphic_table graphicRef97715" href="/z/d/graphic/97715.html" rel="external">
          table 6
         </a>
         ). (See
         <a class="local">
          'Moderate symptoms'
         </a>
         above and
         <a class="local">
          'Severe symptoms'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Children with acute unilateral lymphadenitis who are receiving appropriate antimicrobial therapy usually manifest decreased inflammation and tenderness of the node and decreased maximum daily temperature within 48 to 72 hours. Failure to improve within 48 to 72 hours may indicate infection with a resistant organism, particularly methicillin- or clindamycin-resistant
         <em>
          S. aureus
         </em>
         ; an uncommon or rare infectious cause  (
         <a class="graphic graphic_table graphicRef97718" href="/z/d/graphic/97718.html" rel="external">
          table 5
         </a>
         ); or a noninfectious cause  (
         <a class="graphic graphic_table graphicRef77911" href="/z/d/graphic/77911.html" rel="external">
          table 2
         </a>
         ). (See
         <a class="local">
          'Moderate symptoms'
         </a>
         above and
         <a class="local">
          'Severe symptoms'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Suspected Kawasaki disease or MIS-C
         </strong>
         – Kawasaki disease or multisystem inflammatory syndrome in children (MIS-C) should be suspected in children with acute cervical lymphadenitis and ill-appearance, shock, myocardial dysfunction, or associated gastrointestinal symptoms  (
         <a class="graphic graphic_table graphicRef67711 graphicRef128294" href="/z/d/graphic/67711.html" rel="external">
          table 7A-B
         </a>
         ). The initial evaluations of Kawasaki disease and MIS-C are discussed separately; cardiac testing (eg, echocardiography) usually is included. (See
         <a class="medical medical_review" href="/z/d/html/6417.html" rel="external">
          "Kawasaki disease: Clinical features and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/128190.html" rel="external">
          "COVID-19: Multisystem inflammatory syndrome in children (MIS-C) clinical features, evaluation, and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Subacute/chronic
         </strong>
         – Unilateral subacute/chronic cervical lymphadenitis is usually caused by cat scratch disease or nontuberculous mycobacterial (NTM) infection. However, the possibility of malignancy must be considered, particularly in adolescents. Bilateral subacute/chronic cervical lymphadenitis is usually caused by Epstein-Barr virus (EBV) or cytomegalovirus (CMV). (See
         <a class="local">
          'Subacute/chronic'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         The initial evaluation of children with subacute/chronic cervical lymphadenitis usually includes a complete blood count with differential and smear; ESR and/or CRP; hepatic panel; uric acid and lactate dehydrogenase;
         <a class="drug drug_general" data-topicid="10029" href="/z/d/drug information/10029.html" rel="external">
          tuberculin skin test
         </a>
         ; serologic testing for HIV, EBV, and CMV (if bilateral); and serologic testing for
         <em>
          Bartonella henselae
         </em>
         , tularemia, toxoplasmosis, or plague (if indicated by clinical findings).
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         The initial management of children with subacute/chronic cervical lymphadenitis depends upon the suspected etiology:
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         Excisional biopsy should occur as early in the course as possible if malignancy is suspected. (See
         <a class="local">
          'Suspected malignancy'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         Excisional biopsy is the preferred treatment for NTM lymphadenitis when it can be performed safely. (See
         <a class="medical medical_review" href="/z/d/html/86045.html" rel="external">
          "Nontuberculous mycobacterial lymphadenitis in children", section on 'Management'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         When cat scratch disease is suspected but not confirmed, empiric therapy should provide coverage for
         <em>
          S. aureus
         </em>
         and GAS  (
         <a class="graphic graphic_table graphicRef97715" href="/z/d/graphic/97715.html" rel="external">
          table 6
         </a>
         ) as well as for cat scratch disease (eg,
         <a class="drug drug_pediatric" data-topicid="12937" href="/z/d/drug information/12937.html" rel="external">
          azithromycin
         </a>
         ,
         <a class="drug drug_pediatric" data-topicid="12767" href="/z/d/drug information/12767.html" rel="external">
          rifampin
         </a>
         , or
         <a class="drug drug_pediatric" data-topicid="12816" href="/z/d/drug information/12816.html" rel="external">
          trimethoprim-sulfamethoxazole
         </a>
         ). (See
         <a class="local">
          'Suspected cat scratch disease'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/5530.html" rel="external">
          "Treatment of cat scratch disease", section on 'Lymphadenitis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Uncertain etiology or persistence
         </strong>
         – For children in whom the etiology of lymphadenitis remains uncertain after the initial evaluation or the lymphadenitis has persisted for six to eight weeks with no response to antimicrobial therapy, additional testing, including excisional biopsy, may be indicated to assess uncommon or rare infectious  (
         <a class="graphic graphic_table graphicRef56712" href="/z/d/graphic/56712.html" rel="external">
          table 1
         </a>
         ) and noninfectious causes  (
         <a class="graphic graphic_table graphicRef77911" href="/z/d/graphic/77911.html" rel="external">
          table 2
         </a>
         ) of cervical lymphadenitis. (See
         <a class="local">
          'Additional evaluation for persistence or uncertain etiology'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H101961942">
         <span class="h1">
          ACKNOWLEDGMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         The editorial staff at UpToDate, Inc. acknowledge Dr. Douglas Swanson, who contributed to an earlier version of this topic review.
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Leung AK, Davies HD. Cervical lymphadenitis: etiology, diagnosis, and management. Curr Infect Dis Rep 2009; 11:183.
          </a>
         </li>
         <li class="breakAll">
          Healy CM, Baker CJ. Cervical lymphadenitis. In: Feigin and Cherry’s Textbook of Pediatric Infectious Diseases, 8th ed, Cherry JD, Harrison G, Kaplan SL, et al (Eds), Elsevier, Philadelphia 2018. p.124.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Neff L, Newland JG, Sykes KJ, et al. Microbiology and antimicrobial treatment of pediatric cervical lymphadenitis requiring surgical intervention. Int J Pediatr Otorhinolaryngol 2013; 77:817.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dulin MF, Kennard TP, Leach L, Williams R. Management of cervical lymphadenitis in children. Am Fam Physician 2008; 78:1097.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barton LL, Feigin RD. Childhood cervical lymphadenitis: a reappraisal. J Pediatr 1974; 84:846.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           DAJANI AS, GARCIA RE, WOLINSKY E. Etiology of cervical lymphadenitis in children. N Engl J Med 1963; 268:1329.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brook I. Anaerobic bacteria in upper respiratory tract and head and neck infections: microbiology and treatment. Anaerobe 2012; 18:214.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lindquist NR, Patro A, Gitomer SA, Cañadas KT. Pediatric acute unilateral suppurative lymphadenitis: The role of antibiotic susceptibilities at a large tertiary pediatric care center. Int J Pediatr Otorhinolaryngol 2019; 120:11.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gosche JR, Vick L. Acute, subacute, and chronic cervical lymphadenitis in children. Semin Pediatr Surg 2006; 15:99.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Miller LG, Daum RS, Creech CB, et al. Clindamycin versus trimethoprim-sulfamethoxazole for uncomplicated skin infections. N Engl J Med 2015; 372:1093.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Campbell RM, Douglas PS, Eidem BW, et al. ACC/AAP/AHA/ASE/HRS/SCAI/SCCT/SCMR/SOPE 2014 appropriate use criteria for initial transthoracic echocardiography in outpatient pediatric cardiology: a report of the American College of Cardiology Appropriate Use Criteria Task Force, American Academy of Pediatrics, American Heart Association, American Society of Echocardiography, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Pediatric Echocardiography. J Am Coll Cardiol 2014; 64:2039.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Snowden J, Stovall S. Tularemia: retrospective review of 10 years' experience in Arkansas. Clin Pediatr (Phila) 2011; 50:64.
          </a>
         </li>
         <li class="breakAll">
          World Health Organization. WHO guidelines on tularemia. Geneva, Switzerland: World Health Organization; 2007. http://www.cdc.gov/tularemia/resources/whotularemiamanual.pdf. (Accessed on September 05, 2014).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Choi P, Qin X, Chen EY, et al. Polymerase chain reaction for pathogen identification in persistent pediatric cervical lymphadenitis. Arch Otolaryngol Head Neck Surg 2009; 135:243.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007; 175:367.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Perlman DC, D'Amico R, Salomon N. Mycobacterial Infections of the Head and Neck. Curr Infect Dis Rep 2001; 3:233.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lindeboom JA, Kuijper EJ, Prins JM, et al. Tuberculin skin testing is useful in the screening for nontuberculous mycobacterial cervicofacial lymphadenitis in children. Clin Infect Dis 2006; 43:1547.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Martínez-Planas A, Baquero-Artigao F, Santiago B, et al. Interferon-Gamma Release Assays Differentiate between Mycobacterium avium Complex and Tuberculous Lymphadenitis in Children. J Pediatr 2021; 236:211.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Starke JR, Committee On Infectious Diseases. Interferon-γ release assays for diagnosis of tuberculosis infection and disease in children. Pediatrics 2014; 134:e1763.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fraser L, Moore P, Kubba H. Atypical mycobacterial infection of the head and neck in children: a 5-year retrospective review. Otolaryngol Head Neck Surg 2008; 138:311.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lindeboom JA, Kuijper EJ, Bruijnesteijn van Coppenraet ES, et al. Surgical excision versus antibiotic treatment for nontuberculous mycobacterial cervicofacial lymphadenitis in children: a multicenter, randomized, controlled trial. Clin Infect Dis 2007; 44:1057.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Leung AK, Robson WL. Childhood cervical lymphadenopathy. J Pediatr Health Care 2004; 18:3.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wolinsky E. Mycobacterial lymphadenitis in children: a prospective study of 105 nontuberculous cases with long-term follow-up. Clin Infect Dis 1995; 20:954.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Loizos A, Soteriades ES, Pieridou D, Koliou MG. Lymphadenitis by non-tuberculous mycobacteria in children. Pediatr Int 2018; 60:1062.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 6061 Version 41.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19366560" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Cervical lymphadenitis: etiology, diagnosis, and management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19366560" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Cervical lymphadenitis: etiology, diagnosis, and management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23531371" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Microbiology and antimicrobial treatment of pediatric cervical lymphadenitis requiring surgical intervention.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19007057" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Management of cervical lymphadenitis in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4826618" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Childhood cervical lymphadenitis: a reappraisal.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14024679" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Etiology of cervical lymphadenitis in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22197951" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Anaerobic bacteria in upper respiratory tract and head and neck infections: microbiology and treatment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30743188" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Pediatric acute unilateral suppurative lymphadenitis: The role of antibiotic susceptibilities at a large tertiary pediatric care center.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16616313" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Acute, subacute, and chronic cervical lymphadenitis in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25785967" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Clindamycin versus trimethoprim-sulfamethoxazole for uncomplicated skin infections.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25277848" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : ACC/AAP/AHA/ASE/HRS/SCAI/SCCT/SCMR/SOPE 2014 appropriate use criteria for initial transthoracic echocardiography in outpatient pediatric cardiology: a report of the American College of Cardiology Appropriate Use Criteria Task Force, American Academy of Pediatrics, American Heart Association, American Society of Echocardiography, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Pediatric Echocardiography.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20837613" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Tularemia: retrospective review of 10 years' experience in Arkansas.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20837613" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Tularemia: retrospective review of 10 years' experience in Arkansas.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19289701" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Polymerase chain reaction for pathogen identification in persistent pediatric cervical lymphadenitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17277290" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11384553" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Mycobacterial Infections of the Head and Neck.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17109286" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Tuberculin skin testing is useful in the screening for nontuberculous mycobacterial cervicofacial lymphadenitis in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33984332" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Interferon-Gamma Release Assays Differentiate between Mycobacterium avium Complex and Tuberculous Lymphadenitis in Children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25422024" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Interferon-γrelease assays for diagnosis of tuberculosis infection and disease in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18312877" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Atypical mycobacterial infection of the head and neck in children: a 5-year retrospective review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17366449" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Surgical excision versus antibiotic treatment for nontuberculous mycobacterial cervicofacial lymphadenitis in children: a multicenter, randomized, controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14722499" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Childhood cervical lymphadenopathy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7795100" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Mycobacterial lymphadenitis in children: a prospective study of 105 nontuberculous cases with long-term follow-up.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30290041" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Lymphadenitis by non-tuberculous mycobacteria in children.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
